Fertility and Sterility
Volume 91, Issue 1 , Pages 1-17 , January 2009

Strategies to reduce multiple pregnancies due to ovulation stimulation

Received 5 August 2008 ,Accepted 5 August 2008.

References 

  1. Schenker JG, Yarkoni S, Granat M. Multiple pregnancies following ovulation induction. Fertil Steril. 1981;35:105–123
  2. Dickey RP. The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society for Assisted Reproductive Technology/American Society for Reproductive Medicine recommendation to limit the number of embryos transferred. Fertil Steril. 2007;88:1554–1561
  3. Dickey RP, Taylor SN, Lu PY, Sartor BM, Storment JM, Rye PH, et al. Spontaneous reduction of multiple pregnancy: incidence and effect on outcome. Am J Obstet Gynecol. 2002;186:77–83
  4. Luke B, Brown MB, Maternal morbidity and infant death in twin vs triplet and quadruplet pregnancies. Am J Obstet Gynecol 2098;198:401–3.
  5. Ombelet W, de Sutter P, Van der Elst J, Martens G. Multiple gestation and infertility treatment: registration, reflection and reaction—the Belgian Project. Hum Reprod Update. 2005;11:3–14
  6. Alexander GR, Salihu HM. Perinatal outcomes of singleton and multiple births in the United States, 1995–98. In:  Blickstein I,  Keith LG editor. Multiple pregnancy: epidemiology, gestation, and perinatal outcome. 2nd ed.. London and New York: Taylor and Francis; 2005;p. 3–11
  7. American Society for Reproductive Medicine. Guidelines on number of embryos transferred. A practice committee report. Birmingham, AL: American Society for Reproductive Medicine; 1998;
  8. American Society for Reproductive Medicine. Guidelines on number of embryos transferred. Revised and amended November 1999, a practice committee report. Birmingham, AL: American Society for Reproductive Medicine; 1999;
  9. Gleicher N, Oleske DM, Tur-Kaspa I, Vidali A, Karande V. Reducing the risk of high-order multiple pregnancy after ovarian induction with gonadotropins. N Engl J Med. 2000;343:2–7
  10. The Practice Committee of the American Society for Reproductive Medicine. Multiple pregnancy associated with infertility therapy: educational Bulletin. Fertil Steril. 2006;86(Suppl 4):S106–S110
  11. Jones HW. Multiple births: how are we doing?. Fertil Steril. 2003;79:17–21
  12. Dickey RP. A year of inaction on high-order multiple pregnancies due to ovulation induction. Fertil Steril. 2003;79:14–16
  13. Fritz MA, Ory SJ. Practice guidelines cannot be justifies in the absence of sufficient evidence: inaction is far more appropriate than indefensible action. Fertil Steril. 2003;79:22–24
  14. ACOG. Practice bulletin no. 34: management of infertility caused by ovulatory dysfunction. Obstet Gynecol. 2002;99:347–358
  15. Royal College of Obstetricians and Gynaecologists. Evidence-based clinical guidelines. The management of infertility in secondary care. London: RCOG Press; 1998;
  16. Fauser BCJM, Devroey P, Macklon NS. Multiple birth resulting from ovarian stimulation for infertility treatment. Lancet. 2005;365:1807–1816
  17. Van Rumste MME, den Hartog JE, Dumoulin JCM, Evers JLH, Land JA. Is controlled ovarian stimulation in intrauterine insemination an acceptable therapy in couples with unexplained nonconception in the perspective of multiple pregnancies?. Hum Reprod. 2006;21:701–704
  18. Macgregor AH, Johnson JE, Bunde CA. Further clinical experience with clomiphene citrate. Fertil Steril. 1968;19:616–622
  19. Thompson CR, Hansen LM. Pergonal (menotropins): a summary of clinical experience in the induction of ovulation and pregnancy. Fertil Steril. 1970;21:844–853
  20. American Board of Obstetrics and Gynecology. Maintenance of certification. ABOG Diplomate. 2005;31:1–7
  21. Medical Research International, American Fertility Society Special Interest Group. In vitro fertilization/embryo transfer in the United States: 1985–1986 results from the National IVF-ET Registry. Fertil Steril. 1988;49:212–215
  22. Centers for Disease Control and Prevention, American Society for Reproductive Medicine/Society for Assisted Reproductive Technology. 2004 assisted reproductive technecology society rates. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention; 2006;
  23. Serono Laboratories. Perganol (menotropins for injection USP). [package insert] Randolf, MA: Serono Laboratories; 1969;
  24. Sher G, Knutzen VK, Stratton CJ, Montakhab MM, Allenson SG. In vitro sperm capacitation and transcervical intrauterine insemination for the treatment of refractory infertility: phase I. Fertil Steril. 1984;41:260–264
  25. Dodson WC, Whitesides DB, Hughes CL, Easley HA, Haney AF. Superovulation with intrauterine insemination in the treatment of infertility: a possible alternative to gamete intrafallopian transfer and in vitro fertilization. Fertil Steril. 1987;48:441–445
  26. Tur R, Barri PN, Coroleu B, Buxaderas R, Martinez F, Balasch J. Risk factors for high-order multiple implantation after ovarian induction with gonadotropins: evidence from a large series of 1878 consecutive pregnancies in a single center. Hum Reprod. 2001;16:2124–2129
  27. Oelsner G, Serr DM, Mashiash S, Blankstein J, Synder M, Lunenfels B. The study of induction of ovulation with menotropins: analysis of results of 1897 treatment cycles. Fertil Steril. 1978;30:538–544
  28. Dickey RP, Sartor BM, Pyrzak R. What is the most relevant standard of success in assisted reproduction? No single outcome measure is satisfactory when evaluating success in assisted reproduction; both twin births and singleton births should be counted as successes. Hum Reprod. 2004;19:783–787
  29. Owen DJ, Alfirevic Z. Preterm delivery: a review of the evidence-based literature. In:  Blickstein I,  Keith LG editor. Multiple pregnancy: epidemiology, gestation, and perinatal outcome. 2nd ed.. London and New York: Taylor and Francis; 2005;p. 626–630
  30. Oliver SP, Goldenberg RI, Cutter GR, et al. The relationships among psychosocial profile, maternal size, and smoking in predicting fetal growth retardation. Obstet Gynecol. 1992;80:262–267
  31. Skentou C, Souka Ap, TO MS, et al. Prediction of preterm delivery in twins by cervical assessment at 23 weeks. Ultrasound Obstet Gynecol. 2001;17:7–10
  32. Blickstein I, Goldman RD, Mazkereth R. Risk for one or two very low birth weight twins: a population study. Obstet Gynecol. 2000;96:400–402
  33. Wen SW, Demissie K, Yang Q, Walker MC. Maternal morbidity and obstetric complications in triplet pregnancies and quadruplet and higher-order pregnancies. Am J Obstet Gynecol. 2004;191:254–258
  34. Papiernik E. Preventing preterm birth in twins and triplets. In:  Blickstein I,  Keith LG editor. Multiple pregnancy: epidemiology, gestation, and perinatal outcome. 2nd ed.. London and New York: Taylor and Francis; 2005;p. 631–639
  35. Papiernik E, Richar A, Tafforeau J, Keith LG. Social groups and prevention of preterm births in a population of twin mothers. J Perinat Med. 1996;24:669–676
  36. Blickstein I, Jacques DL, Keith LG. Effect of maternal height on gestational age and birth weight in nulliparous mothers of triplets with a normal pregravid body mass index. J Reprod Med. 2003;48:335–338
  37. Blickstein I, Jacques DL, Keith LG. The likelihood of adverse outcomes in triplet pregnancies estimated by pre-gravid maternal characteristics. Fertil Steril. 2004;81:1079–1082
  38. Valbuena D, Simon C, Romero JL, Remohi J, Pellicer A. Factors responsible for multiple pregnancies after ovarian induction and intrauterine insemination with gonadotropins. J Assist Reprod Genet. 1996;13:663–668
  39. Dickey RP, Taylor SN, Lu PY, Sartor BM, Rye PH, Pyrzak R. Risk factors for high-order multiple pregnancy and multiple birth after controlled ovarian hyperstimulation: results of 4,062 intrauterine insemination cycles. Fertil Steril. 2005;83:671–683
  40. Dickey RP, Taylor SN, Lu PY, Sartor BM, Rye PH, Pyrzak R. Relationship of follicle numbers and estradiol concentrations to multiple implantation of 3608 intrauterine insemination cycles. Fertil Steril. 2001;75:69–78
  41. Shelden R, Kemmann E, Bohrer M, Pasquale S. Multiple gestation is associated with the use of high sperm numbers in the intrauterine insemination in women undergoing gonadotropin induction. Fertil Steril. 1988;49:607–610
  42. Pasqualotto EB, Falcone T, Goldberg JM, Petrauskis C, Nelson DR, Agarwal A. Risk factors for multiple gestation in women undergoing intrauterine insemination with ovarian insemination. Fertil Steril. 1999;72:613–618
  43. Farhi J, West C, Patel A, Jacobs HS. Treatment of anovulatory infertility: the problem of multiple pregnancy. Hum Reprod. 1996;11:429–434
  44. Hughes EG, Collins JA, Gunby J. A randomized controlled trial of three low-dose gonadotropins protocols for unexplained infertility. Hum Reprod. 1998;13:1527–1531
  45. Takokoro N, Vollenhoven B, Clark S, Baker G, Kovacs G, Burger H, et al. Cumulative pregnancy rates in couples with anovulatory infertility compared with unexplained infertility in an ovulation induction program. Hum Reprod. 1997;12:1939–1944
  46. Remohi J, Gastaldi C, Patrizio P, Gerli S, Ord T, Asch RH, et al. Intrauterine insemination and controlled ovarian hyperinduction in cycles before GIFT. Hum Reprod. 1989;4:918–920
  47. Dickey RP, Taylor NN, Lu PY, Sartor MM, Pyrzak R. Clomiphene citrate intrauterine insemination (IUI) before gonadotropin IUI affects the pregnancy rate and high order multiple pregnancy. Fertil Steril. 2004;81:545–550
  48. Dickey RP, Taylor NN, Lu PY, Sartor MM, Rye PH, Pyrzak R. Effect of diagnosis, age, sperm quality, and number of preovulatory follicles on the outcome of multiple cycles of clomiphene citrate–intrauterine insemination. Fertil Steril. 2002;78:1088–1095
  49. Balasch J, Tur R, Alvarez P, Bajo IO, Bosch E, Bruna I, et al The safety and effectiveness of stepwise and low-dose administration of follicle stimulating hormone in WHO group II anovulatory infertile women: evidence from a large multicenter study in Spain. J Assist Reprod Genet. 1996;13:551–556
  50. Alsina JC, Balsa JAR, Sarrio AR, Fernandez VC, Trigo IC, Parga JL, et al. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial. BJOG. 2003;110:1072–1077
  51. Wang JX, Kwan M, Davies MJ, Kirby C, Judd S, Norman . Risk of multiple pregnancy when infertility is treated with ovulation induction by gonadotropins. Fertil Steril. 2003;80:664–665
  52. Papageorgiou TC, Guibert J, Savale M, Goffinet F, Fournier C, Merlet F, et al. Low dose recombinant FSH treatment may reduce multiple gestations caused by controlled ovarian hyperinduction and intrauterine insemination. BJOG. 2004;111:1277–1282
  53. Ragni G, Caliari H, Nicolosi AE, Arnoldi M, Somigliana E, Crosignani PG. Preventing high-order multiple pregnancies during controlled ovarian hyperinduction and intrauterine insemination: 3 years' experience using a low-dose recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril. 2006;85:619–14
  54. Dickey RP, Taylor SN, Curole DN, Rye PH, Lu PY, Pyrzak R. Relationship of clomiphene dose and patient weight to successful treatment. Hum. Reprod. 1997;12:449–453
  55. Goldfarb JM, Peskin B, Austin C, Lisbona H. Evaluation of predictive factors for multiple pregnancies during gonadotropin-IUI treatment. J Assist Reprod Genet. 1997;14:88–91
  56. Dickey RP, Olar TT, Taylor SN, Curole DN, Rye PH. Relationship of follicle number and other factors to fecundability and multiple pregnancies in clomiphene citrate induced intrauterine insemination cycles. Fertil Steril. 1992;57:613–619
  57. Fauser BCJM, Van Heusden AM. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev. 1997;18:71–106
  58. Vollenhoven B, Selub M, Davidson O, Lefkow H, Henault M, Serpa N, et al. Treating infertility: controlled ovarian hyperinduction using human menopausal gonadotropin in combination with intrauterine insemination. J Reprod Med. 1996;41:658–664
  59. Custers IM, Steures P, van der Steeg JW, van Dessel TJHM, Bernardus RE, et al. External validation of a prediction model for an ongoing pregnancy after intrauterine insemination. Fertil Steril. 2007;88:425–430
  60. Tomlinson MJ, Amissah-Arthur JB, Thompson KA, Kasrale JL, Bentick B. Prognostic indicators for intrauterine insemination (IUI): statistical model for IUI success. Hum Reprod. 1996;11:1892–1896
  61. van Wely M, Twisk M, Mol BW, van der Veen F. Is twin pregnancy necessarily an adverse outcome of assisted reproductive technologies?. Hum Reprod. 2006;21:2736–2738
  62. Practice Committee of the Society for Assisted Reproductive Technology, Practice Committee of the American Society for Reproductive Medicine. Guidelines on number of embryos transferred. Fertil Steril. 2006;86(Suppl 4):S51–S52
  63. Lord JM, Flight IHK, Norman RJ. Metformin in polycystic ovary syndrome:systematic review and meta-analysis. BMJ. 2003;327:951–953
  64. Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med. 2007;356:551–566
  65. Guzick DS, Sullivan MW, Adamson GD, Cedars MI, Falk RJ, Peterson EP, et al. Efficacy of treatment for unexplained infertility. Fertil Steril. 1998;70:207–213
  66. Agarwal SK, Buyalos RP. Clomiphene citrate with intrauterine insemination: is it effective therapy in women above the age of 35 years. Fertil Steril. 1996;65:759–763
  67. Park SJ, Alvarez JR, Weiss G, Von Hagen S, Smith D, McGovern PG. Ovulatory status and follicular response predict success of clomiphene citrate–intrauterine insemination. 2007;87:1102–7.
  68. Hammond MG, Halme JK, Talbert LM. Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation. Obstet Gynecol. 1983;62:196–202
  69. MacGregor AH, Johnson JE, Bunde CA. Induction of ovulation with clomiphene citrate. Presented at the 14th Annual Meeting of the Canadian Society for the Study of Fertility; Montreal; June 19–21, 1967.
  70. Dickey RP, Olar TT, Taylor SN, Curole DN, Matulich EM. Relationship of endometrial thickness and pattern to fecundity in ovulation induction cycles: effect of clomiphene citrate alone and with human menopausal gonadotropin. Fertil Steril. 1993;59:756–760
  71. Eden JA, Place J, Carter GD, Jones J, Alaghband-Zadeh J, Pawson ME. The effect of clomiphene on follicular phase increase in endometrial thickness and uterine volume. Fertil Steril. 1989;73:187–190
  72. Roumen FJ, Doesburg WH, Rolland R. Treatment of infertile women with a deficient postcoital test with two antiestrogens: clomiphene and tamoxifen. Fertil Steril. 1989;41:237–243
  73. Avharya U, Irvine DS, Hamilton MPR, templeton AA. The effect of three antioestrogen drugs on cervical mucus quality and in-vitro sperm–cervical mucus interaction in ovulatory women. Hum Reprod. 1993;8:437–441
  74. Yagel S, Ben-Chetrit A, Anteby E, Zacut D, Hochner-Celnikier D, Ron M. The effect of ethinyl estradiol on endometrial thickness and uterine volume during ovulation induction by clomiphene citrate. Fertil Steril. 1992;57:33–36
  75. Steiner AZ, Terplan M, Paulson RJ. Comparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis. Hum Reprod. 2005;20:1511–1515
  76. Boostanfar R, Jain JK, Mishell DR, Paulson RJ. A prospective randomized trial comparing clomiphene citrate for ovulation induction. Fertil Steril. 2001;75:1024–1026
  77. Casper RF. Letrozole: ovulation or superovulation?. Fertil Steril. 2003;80:1335–1337
  78. Fisher SA, Reid RL, Van Vugt DA, Casper RF. A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal. Fertil Steril. 2002;78:280–285
  79. Mitwally MF, Casper RF. Aromatase inhibitors in ovulation induction. Semin Reprod Med. 2004;22:61–78
  80. Biljan MM, Hemmings R, Brassard N. The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertil Steril. 2005;(Suppl 1):84;O-231 (abstr. 1033)
  81. Eijkemans M, Imani B, Mulders A, Habbema J, Fauser B. High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). Hum Reprod. 2003;18:2357–2362
  82. Philips Z, Barraza-Llorens M, Posnett J. Evaluation of the relative cost-effectiveness of treatments for infertility in the UK. Hum Reprod. 2000;15:95–106
  83. Karande VC, Korn A, Morris R, Rao R, Balin M, Rinehart J, et al. Prospective randomized trial comparing the outcome and cost of in vitro fertilization with that of a traditional treatment algorithm as first-line therapy for couples with infertility. Fertil Steril. 1999;71:468–475
  84. Kistner RW. Use of clomiphene citrate, human chorionic gonadotropins and human menopausal gonadotropins for induction of ovulation in the human female. Fertil Steril. 1966;17:569–583
  85. Brzechffa PR, Daneshmand S, Buyalos RP. Sequential clomiphene citrate and human menopausal gonadotropin with intrauterine insemination: the effect of patient age on clinical outcome. Hum Reprod. 1998;13:2110–2114
  86. Nuojua-Huttunen S, Tomas C, Bloigu R, Tuomivaara L, Martikainen H. Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome. Hum Reprod. 1999;14:698–703
  87. Aboulghar M, Mansour M, Serour G, Abdrazek A, Amin Y, Rhodes C. Controlled ovarian hyperinduction and intrauterine insemination should be limited to a maximum of three trials. Fertil Steril. 2001;75:88–91
  88. Dickey RP, Olar TT, Taylor SN, Curole DN, Rye PH. Sequential clomiphene citrate and human menopausal gonadotropin for ovulation induction: comparison to clomiphene citrate alone and human menopausal gonadotropin alone. Hum Reprod. 1993;8:56–5
  89. Bedaiwy MA, Forman R, Mousa NA, Al Inany HG, Casper RA. Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation. Hum Reprod. 2006;21:2838–2844
  90. Van Weissenbruch MM . Gonadotropins for induction of ovulation, immunological, pharmacological and clinical studies. [dissertation] Amsterdam: Free University; 1990;
  91. Ben-Rafael Z, Levy T, Schoemaker J. Pharmacokinetics of follicle stimulating hormone: clinical significance. Fertil Steril. 1995;63:689–700
  92. Homburg R, Howles CM. Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results reflections and refinements. Hum Reprod Update. 1999;3:493–499
  93. White DM, Polson DW, Kiddy D, Sagle P, Watson H, Gilling-Smith C, et al. Induction of ovulation with low-dose gonadotrophins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. J Clin Endocrinol Metab. 1996;81:3821–3824
  94. Hugues JN, Cedrin-Durnerin I, Howles CM. The use of decremental dose regimen in patients treated with a chronic low-dose step-up protocol for WHO group I anovulation: a prospective randomized multicentre study. Hum Reprod. 2006;21:2817–2822
  95. Hohmann EP, Laven JSE, de Jong FH, Eijkemans MJC, Fauser BCJM. Low-dose exogenous FSH initiated during the early, mid, or late follicular phase can induce multiple dominant follicle development. Hum Reprod. 2001;16:846–854
  96. Martin K, Santoro N, Hall J, Filicore M, Wierman M, Crowley WF. Clinical review 15: management of ovulatory disorders with pulsatile gonadotropin-releasing hormone. J Clin Endocrinol Metab. 1990;71:1081A–G
  97. Filicori M, Cognigni GE, Samara A, Melappioni S, Perri T, Cantelli B, et al. The use of LH activity to drive folliculogenesis: exploring uncharted territories in ovulation induction. Hum Reprod Update. 2002;8:543–547
  98. Filicori M, Cognigni GE, Tabarelli C, Pocognoli P, Taraborrelli S, Spettoli D, et al. Induction and growth of antral ovarian follicles by selective LH activity administration in women. Clin Endocrinol Metab. 2002;87:1156–1161
  99. Dickey RP. Pharmacokinetics and pharmacodynamics of exogenous gonadotropin administration. In Filicori M. Fourth World Congress on Ovulation Induction 2004: from anovulation to assisted reproduction. Rome: Aracne; 2004;123–58
  100. Cook AS, Webster BW, Terranova PF, Keel BA. Variation in the biological and biochemical characteristics of human menopausal gonadotropin. Fertil Steril. 1988;49:704–712
  101. Wolfenson C, Groisman J, Couto AS, Hedenfalk M, Cortvrindt RG, et al. Batch to batch consistency of human-derived gonadotrophin preparations compared to recombinant products. Reprod Biomed Online. 2005;10:442–454
  102. Yen SSC, Llerena O, Little B, Pearsom OH. Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man. J Clin Endocrinol. 1968;28:1763–1767
  103. Andersen AN, Devroey P, Arce J-C. Clinical outcome following induction with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod. 2006;21:3217–3227
  104. Filicori M, Graciela E, Cognigni GE, Pocognoli P, Tabarelli C, Ferlini F, et al. Comparison of controlled ovarian stimulation with human menopausal gonadotropin or recombinant follicle-stimulating hormone. Fertil Steril. 2003;80:390–397
  105. Platteau P, Andersen AN, Balen A, Devroey P, Sorensen P, Helmgaard L, et al. Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO group II anovulatory infertility: a randomized controlled study. Hum Reprod. 2006;21:1798–1804
  106. Hock DL, Seifer DB, Kontopoulos E, Ananth CV. Practice patterns among board-certified reproductive endocrinologists regarding high-order multiple gestations: a United States national survey. Obstet Gynecol. 2002;99:763–770
  107. Zikopoulos K, West CP, Thong PW, Kacser EM, Morrison J, We FCW. Homologous intrauterine insemination has no advantage over timed natural intercourse when used in combination with ovulation induction for the treatment of unexplained infertility. Hum Reprod. 1993;8:563–567
  108. Pittrof RU, Shaker A, Dean N, Bekir JS, Campbell S, Tan SL. Success of intrauterine insemination using cryopreserved donor sperm is related to the age of the woman and the number of preovulatory follicles. J Assist Reprod Genet. 1996;13:310–314
  109. American Society for Reproductive Medicine. ASRM educational bulletin: multiple pregnancy associated with infertility therapy, revised. Fertil Steril. 2006;86(Suppl 4):2106–2110
  110. Ragni G, Maggioni P, Guermandi E, Testa A, Baroni E, Colombo M, et al. Efficacy of double intrauterine insemination in controlled ovarian hyperinduction cycles. Fertil Steril. 1999;72:619–622
  111. Guzick DS, Carson SA, Coutifaris C, Overstreet JW, Factor-Litvak P, Steirkampf MP, et al. Efficacy of superovulation and insemination in the treatment of infertility. N Engl J Med. 1999;340:177–183
  112. Tur R, Barri PN, Coroleu B, Buxaderas R, Parera N, Balasch J. Use of a prediction model for high-order multiple implantations after ovarian induction with gonadotropins. Fertil Steril. 2005;83:116–121
  113. Ulug U, Ben-Shlomo I, Bahcecl M. Predictors of success during the coasting period in high-responder patients undergoing controlled ovarian induction for assisted conception. Fertil Steril. 2004;82:238–242
  114. Urman B, Pride SM, Ho Yuen B. Management of overstimulated gonadotropin cycles with a controlled drift period. Hum Reprod. 1992;7:213–217
  115. Hazout A, Porchier J, Frydman R. Une alternative à la superovul embryonnaire: la superovul folliculaire. Gynécologie. 1984;35:119–121
  116. Ingerslev HJ. Selective follicular reduction following ovulation induction by exogenous gonadotropins in polycystic ovarian disease. A novel approach to treatment. Hum Reprod. 1991;6:682–684
  117. Albano C, Platteau P, Nogueira D, Cortvrindt R, Smitz J, Fevroey P. Avoidance of multiple pregnancies after ovulation induction by supernumerary preovulatory follicle reduction. Fertil Steril. 2001;76:820–822
  118. De Geyter C, De Geyter M, Castro E, Bals-Pratsh M, Nieschlag E, Schneider HP. Experience with transvaginal ultrasound-guided aspiration of supernummary follicles for the prevention of multiple pregnancy agter ovulation induction and intrauterine insemination. Fertil Steril. 1996;65:1163–1168
  119. De Geyter C, De Geyter M, Nieschlag E. Low multiple pregnancy rates and reduced frequency of cancellation after ovulation induction with gonadotropins, if eventual supernumerary follicles are aspirated to prevent polyovulation. J Assist Reprod Genet. 1998;15:111–118
  120. Lessing JB, Amit A, Libal Y, Yovel I, Kogosowski A, Peyser MR. Avoidance of cancellation of potential hyperinduction cycles by conversion to in vitro fertilization–embryo transfer. Fertil Steril. 1991;56:75–78
  121. Nisker J, Tummon I, Daniel S, Kaplan B, Yuxpe A. Conversion of cycles involving ovarian hyperinduction with intrauterine insemination to in-vitro induction. Hum Reprod. 1994;9:406–408
  122. Evans MI, Dommergues M, Wapner RJ, Lynch L, Dumez Y, Goldberg JD, et al. Efficacy of transabdominal multifetal pregnancy reduction: collaborative experience among the world's largest centers. Obstet Gynecol. 1993;82:61–66
  123. Evans MI, Berkowitz RL, Wapner RJ, Carpenter J, Goldberg JD, Ayoub MA, et al. Improvement in outcomes of multifetal pregnancy reduction with increased experience. Am J Obstet Gynecol. 2001;184:97–103
  124. Groutz A, Yovel I, Amit A, Yaron Y, Azem F, Lessing JB. Pregnancy outcome after multifetal pregnancy reduction to twins compared with spontaneously conceived twins. Hum Reprod. 1996;11:1334–1336
  125. Torok O, Lapinski R, Salafia CM, Bernasko J, Berkowitz RL. Multifetal pregnancy reduction is not associated with an increased risk of intrauterine growth restriction, except for very-high-order multiples. Am J Obstet Gynecol. 1998;179:221–225
  126. Leondires MP, Ernst SD, Miller BT, Scott RT. Triplets: outcomes of expectant management versus multifetal reduction for 127 pregnancies. Am J Obstet Gynecol. 2000;183:454–459
  127. Evans MI, Kaufman MI, Urban AJ, Britt DW, Fletcher JC. Fetal reduction from twins to a singleton: a reasonable consideration?. Obstet Gynecol. 2004;104:102–109
  128. CDC MMWR Weekly. Contribution of assisted reproductive technology and ovulation-inducing drugs to triplet and higher-order multiple births—United States, 1980–97. 2000:49(24):535–8
  129. Reynolds MA, Schieve LA, Martin JA, Jeng G, Macaluso M. Trends in multiple births conceived using assisted reproductive technology, United States, 1997–2000. Pediatrics. 2003;111:1159–1162
  130. Dickey RP, Sarter BM. The impact of ovulation induction and in vitro fertilization on incidence of multiple gestations. In:  Blickstein I,  Keith LG editor. Multiple pregnancy: epidemiology, gestation, and perinatal outcome. 2nd edition. London and NewYork: Taylor & Francis; 2005;p. 119–139

 R.P.D. has nothing to disclose.

PII: S0015-0282(08)03305-0

doi: 10.1016/j.fertnstert.2008.08.008

Fertility and Sterility
Volume 91, Issue 1 , Pages 1-17 , January 2009

Article Tools